Yuki Kugiyama

Omura, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

On-Treatment Reassessment of Type IV Collagen 7S and M2BPGi-Qt Improves Long-Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B.

On-Treatment Reassessment of Type IV Collagen 7S and M2BPGi-Qt Improves Long-Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 24, 2026

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study.

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 03, 2026

Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C.

Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C.

Journal: Hepatology international

Published: November 30, 2025

Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Hepatology international

Published: April 30, 2025

Clinical Characteristics and Long-Term Prognosis of Primary Biliary Cholangitis in Japan: Results of the 2nd-Generation Nationwide Survey.

Clinical Characteristics and Long-Term Prognosis of Primary Biliary Cholangitis in Japan: Results of the 2nd-Generation Nationwide Survey.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 26, 2025

Lactitol may improve the prognosis of hepatocellular carcinoma through the proliferation of Megasphaera as well as Bifidobacterium.

Lactitol may improve the prognosis of hepatocellular carcinoma through the proliferation of Megasphaera as well as Bifidobacterium.

Journal: Frontiers in medicine

Published: January 28, 2025

Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment.

Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment.

Journal: Clinical and molecular hepatology

Published: September 20, 2024

Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.

Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.

Journal: JHEP reports : innovation in hepatology

Published: August 04, 2024

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals.

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: July 19, 2024

A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis.

A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis.

Journal: Hepatology (Baltimore, Md.)

Published: October 24, 2023

Zinc supplementation with polaprezinc was associated with improvements in albumin, prothrombin time activity, and hemoglobin in chronic liver disease.

Zinc supplementation with polaprezinc was associated with improvements in albumin, prothrombin time activity, and hemoglobin in chronic liver disease.

Journal: Journal of clinical biochemistry and nutrition

Published: September 27, 2023

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma.

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma.

Journal: Cancers

Published: January 16, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026